Laryngeal cancer constitutes 2,63% of all body cancer in India. It is ten times more common in males than in females. Its incidence is 3.29 new case in males and 0.42 new cases in females per 100,000 population. In this slide, we talk about aetiology, TNM classification and staging, histopathology , diagnosis and treatment
2. I. EPIDEMIOLOGY AND HISTOPATHOLOGY
II. AETIOLOGY
III. ANATOMY - SUBDIVISION
IV. TNM CLASSIFICATION AND STAGING
V. DIAGNOSIS OF LARYNGEAL CANCER
VI. TREATMENT OF LARYNGEAL CANCER
3. I. EPIDEMIOLOGY AND HISTOPATHOLOGY
- 2,63% of all body cancer in India
- M : F = 10:1
- Age group: 40-70 years
- 90–95% : squamous cell carcinoma
II. AETIOLOGY
American Cancer Society: Cancer Facts and Figures 2008. Atlanta, Ga: American
Cancer Society, 2008
5. IV. TNM CLASSIFICATION AND STAGING
Source: AJCC Cancer Staging Manual, 6th Ed (2002)
Fixed
6. Source: Greene FL, Page DL, Fleming ID, et al. (editors). American Joint Committee on
Cancer Staging Manual, 6th edition, New York: Springer-Verlag, 2002
IV. TNM CLASSIFICATION AND STAGING
9. V. DIAGNOSIS OF LARYNGEAL CANCER
1. History.
“any patient in cancer age group having persistent or
gradually increasing hoarseness for 3 weeks must have
laryngeal examination to exclude cancer”
- Other symptoms: Throat pain, dysphagia, referred pain in
the ear, or mass of lymph nodes in the neck
- Late feature: Weight loss, stridor, respiratory obstruction,
halitosis
2. Indirect laryngoscopy
- Appearance of lesion
- Vocal cord mobility
- Extent of disease
10. 3. Examination of neck
- Extralaryngeal spread of disease
- Nodal metastasis
4. Radiography: CT scan or MRI:
- Evaluate pre-epiglottic or paraglottic space
- Laryngeal cartilage erosion
- Cervical node metastasis
5. Direct laryngoscopy
- The hidden areas of larynx
- Extent of disease
6. Supravital staining and biopsy
Certain
diagnostic test
V. DIAGNOSIS OF LARYNGEAL CANCER
11. VI. TREATMENT OF LARYNGEAL CANCER
Site and
extent of
lesion (T)
Presence or
absence of
Nodes (N)
Distant
Metastases (M)
Treatment
Radiotherapy Surgery Combined
therapy
Organ
preservation
Conservation
laryngeal surgery
Total
laryngectomy Surgery with
pre- or
postoperative
radiotherapy
Endoscopic
CO2 laser excision
(early stage)
12. GLOTTIC CARCINOMA
1. Carcinoma in situ:
Transoral endoscopic CO2 laser
stripping of vocal cord biopsy
invasive carcinoma
radiotherapy
carcinoma in situ
Regular follow-up.
13. Invasive carcinoma
T1
carcinoma
Radiotherapy
Excision of cord
carcinoma with
extension
to anterior commissure
carcinoma with extension
to arytenoid
Radiotherapy
Frontolateral
partial laryngectomy
total laryngectomy
The
best
absence
Fails
Refused or not avalable
14. - Mobility of vocal cord?
- Involvement of anterior commissure
and/or arytenoid? T2N0
Cord mobile Cord mobility impaired
or
Involvement of anterior
commissure or arytenoid
Conservation
laryngectomy
Total laryngectomy
± neck dissection
Failure
Radiotherapy
Conservation
laryngectomy
Total laryngectomy
± neck dissection
Failure
Failure
Failure
Vertical
hemilaryngectomy
Frontolateral
laryngectomy
15. T3, T4 total laryngectomy + neck dissection
More advanced T4 : combined therapy: surgery + P.R
If nodes are palpable
Or only Palliative treatment
P.R: postoperative radiotherapy
T1,T2 T3,T4
Radiotherapy
Total laryngectomy
and P.R
Subglottic
cancer
17. Supraglottic cancer
T1 T2 T3 , T4
Radiation or
excised with CO2 laser
Lung
function
good poor
supraglottic laryngectomy
With or without
neck dissection radiotherapy
total laryngectomy
with neck
dissection
and P.R to neck
18. Radiotherapy
- Cord mobility: normal
- Invade cartilage or cervical nodes: no
Total laryngectomy:
- T3 lesions (i.e. with cord fixed)
- All T4 lesions
- Invasion of thyroid or cricoid cartilage
- Bilateral arytenoid cartilage involvement
- Lesions of posterior commissure
- Failure after radiotherapy or conservation surgery
- Transglottic cancers, i.e. tumours involving supraglottis
and glottis across the ventricle, causing fixation of the
vocal cord